Global Veterinary Clostridium Vaccine Market 2017-2021

動物用クロストリジウムワクチンの世界市場2017-2021

◆タイトル:Global Veterinary Clostridium Vaccine Market 2017-2021
◆商品コード:IRTNTR13419
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年7月19日
◆ページ数:76
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、動物用クロストリジウムワクチンの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、動物用クロストリジウムワクチンの世界市場規模及び予測、種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

クロストリジウム属の菌は、土壌内部や様々な動物の腸内などで広く生息している嫌気性菌であり、動物の様々な病気に繋がる多くの種類の毒素を持っています。これら病気のいくつかは、人畜共通感染症です。動物をすべてのクロストリジウム感染症から保護する上で、ワクチンは大きな役割を果たしています。Technavio社は動物用クロストリジウムワクチンの世界市場が2017-2021年期間中に年平均4.96%成長すると予測しています。当レポート上に記載されている主な企業は• Elanco• Merck• Merial (now part of Boehringer Ingelheim)• Zoetis等です。

About Veterinary Clostridium Vaccine
Clostridium bacteria are widely found in soil and the guts of various animals. These microbes are anaerobic in nature and produce a wide range of toxins leading to various diseases in animals. Some of these diseases are zoonotic in nature. Vaccines play a major role in protecting the animals against all the Clostridia diseases. Various types of vaccines are available, either in a single form or in combinations, which consist of bacterins, toxoids, or mixtures of bacterins and toxoids.

Technavio’s analysts forecast the global veterinary clostridium vaccine market to grow at a CAGR of 4.96% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global veterinary clostridium vaccine market for 2017-2021. To calculate the market size, the report considers sales of Clostridium vaccines.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Veterinary Clostridium Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Elanco
• Merck
• Merial (now part of Boehringer Ingelheim)
• Zoetis

[Other prominent vendors]
• Advaxis
• AMPLIPHI
• Aratana Therapeutics
• ARKO Labs
• Bayer
• CanFel Therapeutics
• Ceva
• Colorado Serum Company
• Epitopix
• Genus
• Hygieia Biological Laboratories
• NEXVET
• Nuovo Biologics
• Valneva SE
• Vetoquinol
• Virbac

[Market driver]
• Advances in technology
• For a full, detailed list, view our report

[Market challenge]
• Manufacturing and storage issues
• For a full, detailed list, view our report

[Market trend]
• Inorganic growth strategies
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: An overview of Clostridial Disease

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Market segmentation by species type
• Swine
• Bovine
• Poultry
• Others

PART 08: Geographical segmentation
• Veterinary Clostridium vaccine market in Americas
• Veterinary Clostridium vaccine market in EMEA
• Veterinary Clostridium vaccine market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Inorganic growth strategies
• Combination vaccines
• Industry-academia collaborations

PART 12: Vendor landscape
• Competitive scenario
• Competitive landscape analysis

PART 13: Key vendor analysis
• Elanco
• Merck
• Merial (now part of Boehringer Ingelheim)
• Zoetis
• Other prominent vendors

PART 14: Appendix
• List of abbreviations

[List of Exhibits]
Exhibit 01: Various clostridial diseases in animals
Exhibit 02: Global veterinary Clostridium vaccine market snapshot
Exhibit 03: Global veterinary Clostridium vaccine market 2016-2021 ($ millions)
Exhibit 04: Opportunity analysis in global veterinary Clostridium vaccine market
Exhibit 05: Five forces analysis
Exhibit 06: Market segmentation by type of species 2016
Exhibit 07: Global Clostridium swine vaccine market 2016-2021 ($ millions)
Exhibit 08: Species of Clostridium microbes affecting bovine animals
Exhibit 09: Global Clostridium bovine vaccine market 2016-2021 ($ millions)
Exhibit 10: Various commonly reported clostridial diseases in bovine animals
Exhibit 11: Global Clostridium poultry vaccine market 2016-2021 ($ millions)
Exhibit 12: Examples of few major animals from the segment
Exhibit 13: Global veterinary Clostridium vaccine market by other species 2016-2021 ($ millions)
Exhibit 14: Segmentation of global veterinary Clostridium vaccine market by geography 2016 and 2021 (%)
Exhibit 15: Global veterinary Clostridium vaccine market by geography 2016-2021 ($ millions)
Exhibit 16: Market scenario in Americas
Exhibit 17: Veterinary Clostridium vaccine market in Americas 2016-2021 ($ millions)
Exhibit 18: Market scenario in EMEA
Exhibit 19: Veterinary Clostridium vaccine market in EMEA 2016-2021 ($ millions)
Exhibit 20: Market scenario in APAC
Exhibit 21: Veterinary Clostridium vaccine market in APAC 2016-2021 ($ millions)
Exhibit 22: Major factors for CVB product approval
Exhibit 23: Recent strategic alliances in animal healthcare
Exhibit 24: USDA approved combination vaccines
Exhibit 25: Competitive structure analysis of global veterinary Clostridium vaccine market 2016
Exhibit 26: Competitive factors of global veterinary Clostridium vaccine market
Exhibit 27: Market penetration of various veterinary Clostridium vaccine manufacturers worldwide 2016
Exhibit 28: Strategic success factors of companies in global veterinary Clostridium vaccine market
Exhibit 29: Elanco: Key highlights
Exhibit 30: Elanco: Strength assessment
Exhibit 31: Elanco: Strategy assessment
Exhibit 32: Elanco: Opportunity assessment
Exhibit 33: Merck: Key highlights
Exhibit 34: Merck: Strength assessment
Exhibit 35: Merck: Strategy assessment
Exhibit 36: Merck: Opportunity assessment
Exhibit 37: Merial: Key highlights
Exhibit 38: Merial: Strength assessment
Exhibit 39: Merial: Strategy assessment
Exhibit 40: Merial: Opportunity assessment
Exhibit 41: Zoetis: Key highlights
Exhibit 42: Zoetis: Strength assessment
Exhibit 43: Zoetis: Strategy assessment
Exhibit 44: Zoetis: Opportunity assessment
Exhibit 45: Other prominent vendors



【掲載企業】

Elanco, Merck, Merial (now part of Boehringer Ingelheim), Zoetis, Advaxis, AMPLIPHI, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, NEXVET, Nuovo Biologics, Valneva SE, Vetoquinol, and Virbac.

★調査レポート[動物用クロストリジウムワクチンの世界市場2017-2021] (Global Veterinary Clostridium Vaccine Market 2017-2021 / IRTNTR13419)販売に関する免責事項
[動物用クロストリジウムワクチンの世界市場2017-2021] (Global Veterinary Clostridium Vaccine Market 2017-2021 / IRTNTR13419)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆